-
Je něco špatně v tomto záznamu ?
Genomic profile and immune contexture in colorectal cancer-relevance for prognosis and immunotherapy
S. Meršaková, Z. Lasabová, J. Strnádel, M. Kalman, E. Gabonova, P. Sabaka, R. Ciccocioppo, L. Rodrigo, P. Kruzliak, P. Mikolajčík
Jazyk angličtina Země Itálie
Typ dokumentu časopisecké články, přehledy
Grantová podpora
APVV-16-0066
Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR
- MeSH
- imunoterapie MeSH
- inhibitory kontrolních bodů terapeutické užití MeSH
- kolorektální nádory genetika imunologie patologie MeSH
- lidé MeSH
- nádorové mikroprostředí MeSH
- prognóza MeSH
- sekvenční analýza RNA MeSH
- staging nádorů MeSH
- výpočetní biologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Colorectal cancer (CRC) is one of the leading cancers in both genders. TNM staging system is still the most commonly used tumor classification and prognostic system. The disadvantage of TNM is that the prognostic information it provides is incomplete, and patients with the same histological tumor stages may differ significantly in the clinical outcome. Therefore, the identification of new prognostic parameters is crucial. The carcinogenic process that gives rise to an individual tumor is unique and tumor microenviroment should be taken into consideration. In CRC, T-cell infiltration is not homogenous, and recent studies are mostly focusing on memory T-cells and CD8 cells in predicting disease-free survival (DFS) and overall survival (OS). It seems that DFS and OS are not only dependent on microsatellite instable or stable status but mostly on the levels of expression of the immune signatures. Also, patients with high infiltration of cytotoxic and memory cells have significantly better outcome. This review consolidates current knowledge and recent research about importance of immune-cell-associated proteins, specific gene profiles of immune cells and immunotherapy in CRC. We also discussed cell-specific signatures in cancer treatment.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004382
- 003
- CZ-PrNML
- 005
- 20220616091618.0
- 007
- ta
- 008
- 220113s2021 it f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10238-020-00649-w $2 doi
- 035 __
- $a (PubMed)32720224
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a it
- 100 1_
- $a Meršaková, Sandra $u Division of Oncology, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia
- 245 10
- $a Genomic profile and immune contexture in colorectal cancer-relevance for prognosis and immunotherapy / $c S. Meršaková, Z. Lasabová, J. Strnádel, M. Kalman, E. Gabonova, P. Sabaka, R. Ciccocioppo, L. Rodrigo, P. Kruzliak, P. Mikolajčík
- 520 9_
- $a Colorectal cancer (CRC) is one of the leading cancers in both genders. TNM staging system is still the most commonly used tumor classification and prognostic system. The disadvantage of TNM is that the prognostic information it provides is incomplete, and patients with the same histological tumor stages may differ significantly in the clinical outcome. Therefore, the identification of new prognostic parameters is crucial. The carcinogenic process that gives rise to an individual tumor is unique and tumor microenviroment should be taken into consideration. In CRC, T-cell infiltration is not homogenous, and recent studies are mostly focusing on memory T-cells and CD8 cells in predicting disease-free survival (DFS) and overall survival (OS). It seems that DFS and OS are not only dependent on microsatellite instable or stable status but mostly on the levels of expression of the immune signatures. Also, patients with high infiltration of cytotoxic and memory cells have significantly better outcome. This review consolidates current knowledge and recent research about importance of immune-cell-associated proteins, specific gene profiles of immune cells and immunotherapy in CRC. We also discussed cell-specific signatures in cancer treatment.
- 650 _2
- $a kolorektální nádory $x genetika $x imunologie $x patologie $7 D015179
- 650 _2
- $a výpočetní biologie $7 D019295
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a inhibitory kontrolních bodů $x terapeutické užití $7 D000082082
- 650 _2
- $a imunoterapie $7 D007167
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a sekvenční analýza RNA $7 D017423
- 650 _2
- $a nádorové mikroprostředí $7 D059016
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Lasabová, Zora $u Department of Molecular Biology and Genomics, Jessenius Faculty of Medicine, Comenius University in Bratislava, Mala Hora 4, 036 01, Martin, Slovakia. zora.lasabova@uniba.sk
- 700 1_
- $a Strnádel, Ján $u Division of Molecular Medicine, Biomedical Center Martin, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Martin, Slovakia
- 700 1_
- $a Kalman, Michal $u Department of Pathological Anatomy, Jessenius Faculty of Medicine in Martin, University Hospital, Comenius University in Bratislava, Martin, Slovakia
- 700 1_
- $a Gabonova, Eva $u Clinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin, University Hospital, Comenius University in Bratislava, Martin, Slovakia
- 700 1_
- $a Sabaka, Peter, $u Department of Infectiology and Geographical Medicine, Faculty Medicine, Comenius University and University Hospital, Bratislava, Slovakia $d 1984- $7 xx0129262
- 700 1_
- $a Ciccocioppo, Rachele $u Gastroenterology Unit, Department of Medicine, Azienda Ospedaliera Universitaria Integrata Policlinico GB Rossi, University of Verona, Verona, Italy
- 700 1_
- $a Rodrigo, Luis $u Faculty of Medicine, Central University Hospital of Asturias (HUCA), University of Oviedo, Oviedo, Spain
- 700 1_
- $a Kruzliak, Peter $u Second Department of Surgery, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Pekarska 53, 65691, Brno, Czech Republic. kruzliakpeter@gmail.com
- 700 1_
- $a Mikolajčík, Peter $u Clinic of Surgery and Transplant Center, Jessenius Faculty of Medicine in Martin, University Hospital, Comenius University in Bratislava, Martin, Slovakia
- 773 0_
- $w MED00006222 $t Clinical and experimental medicine $x 1591-9528 $g Roč. 21, č. 2 (2021), s. 195-204
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32720224 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220616091612 $b ABA008
- 999 __
- $a ok $b bmc $g 1751748 $s 1155531
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 21 $c 2 $d 195-204 $e 20200727 $i 1591-9528 $m Clinical and Experimental Medicine $n Clin Exp Med $x MED00006222
- GRA __
- $a APVV-16-0066 $p Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR
- LZP __
- $a Pubmed-20220113